Home › Funds › Casdin Capital › RAPP
Casdin Capital position in RAPP
RAPPORT THERAPEUTICS INC · Health Care
Casdin Capital reported holding 200,000 shares of RAPP (RAPPORT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 0.29% of its reported portfolio and ranking #35 among its reported holdings. Casdin Capital first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Casdin Capital's RAPP position evolved
Casdin Capital first disclosed a stake in RAPP in Q3 2026 at 200,000 shares (US$6.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 200.00K | $6.72M | New |
About RAPP and 13F data
RAPP (RAPPORT THERAPEUTICS INC) is a Health Care company. 49 other funds we track also report a position in RAPP — the largest reported positions include TRV GP V, LLC (US$211.0M), ARCH Venture Management, LLC (US$125.3M), Cormorant Asset Management, LP (US$82.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RAPP
- TRV GP V, LLC 6.28M sh · $211.03M · Q3 2026
- ARCH Venture Management, LLC 3.73M sh · $125.29M · Q3 2026
- Cormorant Asset Management, LP 2.46M sh · $82.57M · Q3 2026
- Sofinnova Investments, Inc. 1.90M sh · $63.99M · Q3 2026
- JOHNSON & JOHNSON 1.78M sh · $59.96M · Q3 2026
- BAKER BROS. ADVISORS LP 1.55M sh · $51.98M · Q3 2026
- TRV GP VI, LLC 969.22K sh · $32.57M · Q3 2026
- PERCEPTIVE ADVISORS LLC 724.34K sh · $24.34M · Q3 2026
- Siren, L.L.C. 641.47K sh · $21.55M · Q3 2026
- Sio Capital Management, LLC 291.23K sh · $9.79M · Q3 2026
- Artia Global Partners LP 166.51K sh · $5.59M · Q3 2026
- Ikarian Capital, LLC 166.40K sh · $5.59M · Q3 2026
More on Casdin Capital
FAQ
How long has Casdin Capital held RAPP?
Casdin Capital has disclosed RAPP holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Casdin Capital's current position in RAPP?
As of Q3 2026, Casdin Capital holds 200.00K shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $6.72M, representing 0.29% of its reported portfolio and ranking #35.
Has Casdin Capital been buying or selling RAPP?
In the latest 13F filing (Q3 2026), Casdin Capital newly opened its position in RAPP.
Which other funds hold RAPP?
Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.